✦ LIBER ✦

Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)

✍ Scribed by Roman Hájek, Richard Bryce, Sunhee Ro, Barbara Klencke, Heinz Ludwig

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A377 Phase II Study of Carfilzomib in Pa

✍ Jagannath, S; Vij, R; Stewart, AK; Somlo, G; Jakubowiak, A; Reiman, T; Trudel, S 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 85 KB

9236 Results of PX-171–003-A0, part 1 of

✍ Siegel, D.; Vij, R.; Stewart, K.; Somlo, G.; Jakubowiak, A.; Kukreti, V.; Bahlis 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

An Open-Label Single-Arm Pilot Phase II

✍ Jagannath, Sundar; Vij, Ravi; Stewart, A. Keith; Trudel, Suzanne; Jakubowiak, An 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 400 KB